VGF and ovarian cancer: We screened 9,000 compounds to identify drugs that enhance the ability of a recombinant vaccinia virus lacking VGF and F1 (ΔVF) to induce death of ID8 <i>Trp53</i> <sup>-/-</sup> murine ovarian cancer cells.